-
1
-
-
0032414615
-
Molecular genetics of the human cytochrome P450 monooxygenase super-family[J]
-
Smith G, Stubbins M J, Harries L W, et al. Molecular genetics of the human cytochrome P450 monooxygenase super-family[J]. Xenobiotica, 1998, 28(12): 1129-1165.
-
(1998)
Xenobiotica
, vol.28
, Issue.12
, pp. 1129-1165
-
-
Smith, G.1
Stubbins, M.J.2
Harries, L.W.3
-
2
-
-
33646674486
-
-
Rifkind A B. CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates[J]. Drug Metab Rev, 2006, 38(1-2): 291-335.
-
Rifkind A B. CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates[J]. Drug Metab Rev, 2006, 38(1-2): 291-335.
-
-
-
-
3
-
-
24644457152
-
Carcinogenic risks of dioxin: Mechanistic considerations[J]
-
Schwarz M, Appel K E. Carcinogenic risks of dioxin: mechanistic considerations[J]. Regul Toxicol Pharmacol, 2005, 43 (1): 19-34.
-
(2005)
Regul Toxicol Pharmacol
, vol.43
, Issue.1
, pp. 19-34
-
-
Schwarz, M.1
Appel, K.E.2
-
4
-
-
14944344680
-
Steroids as procarcinogenic agents[J]
-
Bradlow H L, Sepkovic D W. Steroids as procarcinogenic agents[J]. Ann N Y Acad Sci, 2004, 1028(2): 216-232.
-
(2004)
Ann N Y Acad Sci
, vol.1028
, Issue.2
, pp. 216-232
-
-
Bradlow, H.L.1
Sepkovic, D.W.2
-
5
-
-
0037803539
-
How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo? [J]
-
Tanaka E, Kurata N, Yasuhara H. How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo? [J]. J Clin Pharm Ther, 2003, 28(3): 157-165.
-
(2003)
J Clin Pharm Ther
, vol.28
, Issue.3
, pp. 157-165
-
-
Tanaka, E.1
Kurata, N.2
Yasuhara, H.3
-
6
-
-
0036073564
-
Cytochrome P450 phenotyping/genotyping in patients receiving antipsychotics: Useful aid to prescribing? [J]
-
Dahl M L. Cytochrome P450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing? [J]. Clin Pharmacokinet, 2002, 41(7): 453-470.
-
(2002)
Clin Pharmacokinet
, vol.41
, Issue.7
, pp. 453-470
-
-
Dahl, M.L.1
-
7
-
-
33847376979
-
Impaired clearance of phenacetin in hepatic cirrhosis and fibrosis[J]
-
Qu Z Q, Li X D, Liu H L, et al. Impaired clearance of phenacetin in hepatic cirrhosis and fibrosis[J]. Int J Clin Pharmacol Ther, 2007, 45(1): 55-62.
-
(2007)
Int J Clin Pharmacol Ther
, vol.45
, Issue.1
, pp. 55-62
-
-
Qu, Z.Q.1
Li, X.D.2
Liu, H.L.3
-
8
-
-
0032906717
-
Direct determination of paracetamol and its metabolites in urine and serum by capillary electrophoresis with ultraviolet and mass spectrometric detection[J]
-
Heitmeier S, Blaschke G. Direct determination of paracetamol and its metabolites in urine and serum by capillary electrophoresis with ultraviolet and mass spectrometric detection[J]. J Chromatogr B Biomed Sci Appl, 1999, 721 (1): 93-108.
-
(1999)
J Chromatogr B Biomed Sci Appl
, vol.721
, Issue.1
, pp. 93-108
-
-
Heitmeier, S.1
Blaschke, G.2
-
9
-
-
0142155211
-
Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of paracetamol and its major metabolites in rabbit plasma and urine after a toxic dose[J]
-
Vertzoni M V, Archontaki H A, Galanopoulou P. Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of paracetamol and its major metabolites in rabbit plasma and urine after a toxic dose[J]. J Pharm Biomed Anal, 2003, 32 (3): 487-493.
-
(2003)
J Pharm Biomed Anal
, vol.32
, Issue.3
, pp. 487-493
-
-
Vertzoni, M.V.1
Archontaki, H.A.2
Galanopoulou, P.3
-
10
-
-
38449091471
-
-
Chinese source.
-
Chinese source.
-
-
-
-
11
-
-
38449087107
-
-
Chinese source.
-
Chinese source.
-
-
-
|